biostudies-literatureUnknown13(5)Garriga-Baraut TThermo Fisher ScientificAlk-AbellóAllergy-TherapeuticsRoxallStallergenes Greer LaboratoriesLetiDiaterHal-Allergy<h4>Background</h4>Recognition of specific allergens triggering immune response is key for the appropriate prescription of allergen-specific immunotherapy (SIT). This study aimed at evaluating the impact of using the commercially available microarray ImmunoCAP^TM ISAC 112 (Thermo Fisher Scientific) on the etiological diagnosis and SIT prescription compared to the conventional diagnostic methods in patients with allergic rhinitis/rhinoconjunctivitis and/or asthma.<h4>Methods</h4>300 patients with respiratory allergic disease, sensitized to three or more pollen aeroallergens from different species, as assessed by a skin prick test (SPT) and specific IgE assays (sIgE), were included in this multicentric, prospective observational study. SPT and a blood test were performed to all patClinical and translational allergye12246https://www.ebi.ac.uk/biostudies/studies/S-EPMC10154984biostudies-literatureINMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia.PMC10154984Comitè d’Al·lèrgia Respiratòria de Catalunya, SpainBobolea IFarrarons LMiquel STena MBartra JLabrador-Horrillo MPedemonte CGarriga-Baraut TMoncin MMSMAsensio ODe Linares CRaga EVinas MMunoz-Cano RPadro-Casas CBelmonte JfalseINMUNOCAT study: The impact of molecular diagnosis on immunotherapy prescription in pollen polysensitized patients from Catalonia.<h4>Background</h4>Recognition of specific allergens triggering immune response is key for the appropriate prescription of allergen-specific immunotherapy (SIT). This study aimed at evaluating the impact of using the commercially available microarray ImmunoCAP^TM ISAC 112 (Thermo Fisher Scientific) on the etiological diagnosis and SIT prescription compared to the conventional diagnostic methods in patients with allergic rhinitis/rhinoconjunctivitis and/or asthma.<h4>Methods</h4>300 patients with respiratory allergic disease, sensitized to three or more pollen aeroallergens from different species, as assessed by a skin prick test (SPT) and specific IgE assays (sIgE), were included in this multicentric, prospective observational study. SPT and a blood test were performed to all pat2023-01-01T00:00:00Z2023 May2025-07-05T03:05:05.841Z2025-02-19T03:30:33.054ZS-EPMC101549843722741810.1002/clt2.12246